What Is Incurred Sample Reanalysis (ISR) and Why Does It Matter in Bioanalytical Studies?
Introduction: The Real Test of a Bioanalytical Method Begins After Validation Method validation confirms that a bioanalytical method performs reliably […]
Extractables and Leachables (E&L) Testing for Autoinjectors and Wearable Drug Delivery Devices
Primary Regulatory and Technical Challenges in Combination Device Development Chemical migration assessment for drug-device combination systems plays a central role
EMA vs FDA Bioanalytical Method Validation: Key Regulatory Differences Explained
Introduction: Why EMA vs FDA Bioanalytical Method Validation Differences Matter Understanding EMA vs FDA Bioanalytical Method Validation Differences is extremely
EMA vs FDA Bioanalytical Method Validation: Key Regulatory Differences Explained Read More »
Common Reasons Biosimilars Fail Analytical Comparability (and How to Fix Them)
Introduction: A reliable peptide purity testing report should provide a complete analytical overview that confirms peptide identity, purity, composition, and
Common Reasons Biosimilars Fail Analytical Comparability (and How to Fix Them) Read More »
Critical Quality Attributes (CQAs) in Biosimilars: How Mass Spectrometry Supports Evaluation
Introduction: Why Critical Quality Attributes (CQAs) in Biosimilars Need Advanced Analysis The evaluation of Critical Quality Attributes (CQAs) in Biosimilars
PLGA Implants vs Microspheres: Analytical Differences in Polymer Characterization and Drug Release
Comparative Analytical Framework for PLGA Systems PLGA Implant vs Microsphere Characterization focuses on understanding how PLGA polymer structure affects the
Extractables and Leachables Testing for Pre-Filled Syringes: Key Challenges and Solutions
Introduction: Why E&L Testing for Pre-Filled Syringes Requires a Specialized Strategy E&L Testing for Pre-Filled Syringes is much more complex
Biosimilar Comparability Studies: Mass Spectrometry-Based Fingerprinting Approach
Introduction: Biosimilar Comparability Studies use an advanced fingerprinting strategy to prove that a follow-on biologic is highly similar to its
Biosimilar Comparability Studies: Mass Spectrometry-Based Fingerprinting Approach Read More »
Impurity and Sequence Variant Profiling of Biosimilars Using High-Resolution Mass Spectrometry
Introduction: The Analytical Importance of Impurity Profiling of Biosimilars Impurity Profiling of Biosimilars is one of the most important steps
Charge Variant Analysis in Biosimilars: Mass Spectrometry Approaches for Heterogeneity
Why is Charge Variant Analysis in Biosimilars Important for Regulatory Approval? Charge Variant Analysis in Biosimilars is an essential part
Charge Variant Analysis in Biosimilars: Mass Spectrometry Approaches for Heterogeneity Read More »